Related Experiment Video
Updated: Jul 5, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Pneumonia caused by methicillin-resistant Staphylococcus aureus
Ethan Rubinstein1, Marin H Kollef, Dilip Nathwani
1University of Manitoba, Winnipeg, Canada.
Abstract:
A recent increase in staphylococcal infections caused by methicillin-resistant Staphylococcus aureus (MRSA), combined with frequent, prolonged ventilatory support of an aging, often chronically ill population, has resulted in a large increase in cases of MRSA pneumonia in the health care setting. In addition, community-acquired MRSA pneumonia has become more prevalent. This type of pneumonia historically affects younger patients, follows infection with influenza virus, and is often severe, requiring hospitalization and causing the death of a significant proportion of those affected. Ultimately, hospital-acquired MRSA and community-acquired MRSA are important causes of pneumonia and present diagnostic and therapeutic challenges. Rapid institution of appropriate antibiotic therapy, including linezolid as an alternative to vancomycin, is crucial. Respiratory infection-control measures and de-escalation of initial broad-spectrum antibiotic regimens to avoid emergence of resistant organisms are also important. This article reviews the clinical features of, diagnosis of, and therapies for MRSA pneumonia.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia, both hospital- and community-acquired, is a growing concern. Prompt antibiotic treatment and infection control are vital for managing this severe respiratory infection.
Area of Science:
- Infectious Diseases
- Pulmonology
- Critical Care Medicine
Background:
- Increasing incidence of methicillin-resistant Staphylococcus aureus (MRSA) infections.
- Prolonged mechanical ventilation in aging and chronically ill patients contributes to healthcare-associated MRSA pneumonia.
- Rising prevalence of severe community-acquired MRSA pneumonia, particularly in younger individuals post-influenza.
Purpose of the Study:
- To review the clinical features, diagnosis, and therapeutic strategies for MRSA pneumonia.
- To highlight the challenges in managing both hospital-acquired and community-acquired MRSA pneumonia.
- To emphasize the importance of timely and appropriate antibiotic interventions.
Main Methods:
- Review of clinical features of MRSA pneumonia.
- Discussion of diagnostic approaches for MRSA pneumonia.
- Analysis of current and alternative therapeutic options for MRSA pneumonia, including antibiotic choices and infection control measures.
Main Results:
- MRSA pneumonia presents significant diagnostic and therapeutic challenges.
- Early administration of effective antibiotics, such as vancomycin or linezolid, is critical.
- Respiratory infection control and judicious antibiotic de-escalation are essential to prevent resistance.
Conclusions:
- Both hospital-acquired and community-acquired MRSA pneumonia are significant clinical problems.
- Rapid diagnosis and appropriate antibiotic therapy are crucial for improving patient outcomes.
- Implementing infection control measures and antimicrobial stewardship are key to combating MRSA pneumonia.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Mechanism of Antibiotic Resistance in MRSA
Atypical Pneumonia
Clinical Significance of Antibiotic Resistance
Pneumonia III: Complications and Assessment
